Abstract
Telomerase activation is observed in almost 90% of human cancers but not in normal tissues of somatic origin and thus is a critical step for multistep carcinogenesis. A more thorough understanding of telomerase regulation may provide not only a molecular basis of cancer progression but also as a way to manipulate telomerase activity as a potential therapeutic modality. Recent progress in studies on telomerase regulation has shown that telomerase activation is achieved at various steps, including transcriptional and post-transcriptional levels of the telomerase reverse transcriptase (hTERT) gene. Although a number of potentially important mechanisms of telomerase activation have been proposed, none of the current models can fully explain tumor-specific activation of telomerase, suggesting a need for further extensive analysis. This review includes a summary of recent works on telomerase regulation and a discussion of how we can overcome this situation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akalin A, Elmore LW, Forsythe HL, Amaker BA, McCollum ED, Nelson PS, Ware JL, Holt SE . 2001 Cancer Res. 61: 4791–4796
Aldous WK, Marean AJ, DeHart MJ, Matej LA, Moore KH . 1999 Cancer 85: 1523–1529
Allsopp RC, Vaziri H, Patterson C . 1992 Proc. Natl. Acad. Sci. USA 89: 10114–10118
Alitalo K, Koskinen P, Makela TP, Saksela K, Sistonen L, Winqvist R . 1987 Biochim. Biophys Acta. 907: 1–32
Blackburn EH . 1991 Nature 350: 569–573
Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE . 1998 Science 279: 349–352
Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR . 1995 EMBO J. 14: 4240–4248
Burger AM, Double JA, Newell DR . 1997 Eur. J. Cancer 33: 638–644
Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ, Greider CW, DePinho RA . 1999 Cell 97: 527–538
Clark GM, Osborne CK, Levitt D, Wu F, Kim NW . 1997 J. Natl. Cancer Inst. 89: 1874–1881
Colgin LM, Wilkinson C, Englezou A, Kilian A, Robinson MO, Reddel RR . 2000 Neoplasia 2: 426–432
Cong YS, Bacchetti S . 2000 J. Biol. Chem. 275: 35665–35668
Cong YS, Wen J, Bacchetti S . 1999 Hum. Mol. Genet. 8: 137–142
Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S . 1992 EMBO J. 11: 1921–1929
Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S . 1995 Blood 85: 2315–2320
Crowe DL, Nguyen DC, Tsang KJ, Kyo S . 2001 Nucleic Acids Res. 29: 2789–2794
Cuthbert AP, Bond J, Trott DA, Gill S, Broni J, Marriott A, Khoudoli G, Parkinson EK, Cooper CS, Newbold RF . 1999 J. Natl. Cancer Inst. 91: 37–45
Dessain SK, Yu H, Reddel RR, Beijersbergen RL, Weinberg RA . 2000 Cancer Res. 60: 537–541
Devereux TR, Horikawa I, Anna CH, Annab LA, Afshari CA, Barrett JC . 1999 Cancer Res. 59: 6087–6090
Doetzlhofer A, Rotheneder H, Lagger G, Koranda M, Kurtev V, Brosch G, Wintersberger E, Seiser C . 1999 Mol. Cell. Biol. 19: 5504–5511
Ducrest AL, Amacker M, Mathieu YD, Cuthbert AP, Trott DA, Newbold RF, Nabholz M, Lingner J . 2001 Cancer Res. 61: 7594–7602
Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MAS . 1997 Blood 90: 182–193
Feng J, Funk WD, Wang SS, Weinrich AAA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrew WH, Greider CW, Villeponteau B . 1995 Science 269: 1236–1241
Fujimoto K, Kyo S, Takakura M, Kanaya T, Kitagawa Y, Itoh H, Takahashi M, Inoue M . 2000 Nucleic Acids Res. 28: 2557–2562
Fuxe J, Akusjarvi G, Goike HM, Roos G, Collins VP, Pettersson RF . 2000 Cell Growth Differ. 11: 373–384
Gewin L, Galloway DA . 2001 J. Virol. 75: 7198–7201
Greenberg RA, O'Hagan RC, Deng H, Xiao Q, Hann SR, Adams RR, Lichtsteiner S, Chin L, Morin GB, DePinho RA . 1999 Oncogene 18: 1219–1226
Greider CW, Blackburn EH . 1989 Nature 337: 331–337
Gu J, Kagawa S, Takakura M, Kyo S, Inoue M, Roth JA, Fang B . 2000 Cancer Res. 60: 5359–5364
Gunes C, Lichtsteiner S, Vasserot AP, Englert C . 2000 Cancer Res. 60: 2116–2121
Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA . 1999 Nature 400: 464–468
Harle-Bachor C, Boukamp P . 1996 Proc. Natl. Acad. Sci. USA 93: 6476–6481
Harley CB, Futcher BA, Greider CW . 1990 Nature 345: 458–460
Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE . 1997 Cell 89: 341–347
Heinzel T, Lavinsky RM, Mullen TM, Sonderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo D, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG . 1997 Nature 387: 43–48
Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, Hiyama K, Piatyszek MA . 1996 J. Natl. Cancer Inst. 88: 116–122
Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW . 1995a Nat. Med. 1: 249–255
Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M . 1995b J. Immunol. 155: 3711–3715
Holt SE, Aisner D, Baur J, Tesmer VM, Dy M, Ouellette M, Trager JB, Morin GB, Toft DO, Shay JW, Wright WE, White MA . 1999 Genes Dev. 13: 817–826
Holt SE, Aisner DL, Shay JW, Wright WE . 1997 Proc. Natl. Acad. Sci. USA 94: 10687–10692
Horikawa I, Cable PL, Afshari C, Barrett JC . 1999 Cancer Res. 59: 826–830
Kagawa S, Fujiwara T, Kadowaki Y, Fukazawa T, Sok-Joo R, Roth JA, Tanaka N . 1999 Cell Death Differ. 6: 765–772
Kanaya T, Kyo S, Hamada K, Takakura M, Kitagawa Y, Harada H, Inoue M . 2000 Clin. Cancer Res. 6: 1239–1247
Kang SS, Kwon T, Kwon DY, Do SI . 1999 J. Biol. Chem. 274: 13085–13090
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW . 1994 Science 266: 2011–2015
Kinoshita T, Shirasawa H, Shino Y, Moriya H, Desbarats L, Eilers M, Shimizu B . 1997 Virology 232: 53–61
Klingelhutz AJ, Foster SA, McDougall JK . 1996 Nature 380: 79–82
Koga S, Hirohata S, Kondo Y, Komata T, Takakura M, Inoue M, Kyo S, Kondo S . 2000 Hum. Gene Ther. 10: 1397–1406
Komata T, Kondo Y, Kanzawa T, Hirohata S, Koga S, Sumiyoshi H, Srinivasula SM, Barna BP, Alnemri ES, Germano IM, Takakura M, Inoue M, Alnemri ES, Shay JW, Kyo S, Kondo S . 2001 Cancer Res. 61: 5796–5802
Kunimura C, Kikuchi K, Ahmed N, Shimizu A, Yasumoto S . 1998 Oncogene 17: 187–197
Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, Orimo A, Inoue M . 1999 Cancer Res. 59: 5917–5921
Kyo S, Takakura M, Kohama T, Inoue M . 1997 Telomerase activity in human endometrium Cancer Res. 57: 610–614
Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M, Ariga H, Inoue M . 2000 Nucleic Acids Res. 28: 669–677
Kyo S, Takakura M, Tanaka M, Kanaya T, Inoue M . 1998 Int. J. Cancer 79: 66–70
Kyo S, Ueno H, Kanaya T, Inoue M . 1996 Clin. Cancer Res. 2: 2023–2028
Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, Eisenman RN . 1997 Cell 89: 349–356
Li H, Zhao LL, Funder JW, Liu JP . 1997 J. Biol. Chem. 272: 16729–16732
Li H, Zhao L, Yang Z, Funder JW, Liu JP . 1998 J. Biol. Chem. 273: 33436–33442
Liu K, Hodes RJ, Weng NP . 2001 J. Immunol. 166: 4826–4830
Marks PA, Richon VM, Rifkind RA . 2000 J. Natl. Cancer Inst. 92: 1210–1216
Masutomi K, Kaneko S, Hayashi N, Yamashita T, Shirota Y, Kobayashi K, Murakami S . 2000 J. Biol. Chem. 275: 22568–22573
Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA . 1997 Cell 90: 785–795
Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR . 1997 Science 277: 955–959
Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Tahara E, Ide T, Ishikawa F . 1998 Nat. Genet. 18: 65–68
Oh S, Song YH, Yim J, Kim TK . 1999 J. Biol. Chem. 274: 37473–37478
Oh S, Song YH, Yim J, Kim TK . 2000 Oncogene 19: 1485–1490
Oh ST, Kyo S, Laimins LA . 2001 J. Virol. 75: 5559–5566
Richon VM, Sandhoff TW, Rifkind RA, Marks PA . 2000 Proc. Natl. Acad. Sci. USA 97: 10014–10019
Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, Greider C, DePinho RA . 1999 Cell 96: 701–712
Sawa H, Kamada H, Ohshima TA, Noguchi A, Itoh N, Saruta K, Hara M, Saito I . 1999 J. Neurooncol. 42: 45–57
Shay JW, Bacchetti S . 1997 Eur. J. Cancer 33: 787–791
Snijders PJ, van Duin M, Walboomers JM, Steenbergen RD, Risse EK, Helmerhorst TJ, Verheijen RH, Meijer CJ . 1998 Cancer Res. 58: 3812–3818
Soda H, Raymond E, Sharma S, Lawrence R, Davidson K, Oka M, Kohno S, Izbicka E, Von Hoff DD . 2000 Prostate 43: 161–168
Sowa Y, Orita T, Minamikawa-Hiranabe S, Mizuno T, Nomura H, Sakai T . 1999 59: 4266–4270
Stein GS, Montecino M, van Wijnen AJ, Stein JL, Lian JB . 2000 Cancer Res. 60: 2067–2076
Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, Yutsudo M, Inoue M . 1999 Cancer Res. 59: 551–557
Takakura M, Kyo S, Kanaya T, Tanaka M, Inoue M . 1998 Cancer Res. 58: 1558–1561
Takakura M, Kyo S, Sowa Y, Wang Z, Yatabe N, Maida Y, Tanaka M, Inoue M . 2001 Nucleic Acids Res. 29: 3006–3011
Tanaka M, Kyo S, Takakura M, Kanaya T, Sagawa T, Yamashita K, Okada Y, Hiyama E, Inoue M . 1998 Am. J. Pathol. 153: 1985–1991
Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR . 1998 Cancer Res. 58: 4168–4172
Ulaner GA, Hu JF, Vu TH, Oruganti H, Giudice LC, Hoffman AR . 2000 Int. J. Cancer 85: 330–335
Veldman T, Horikawa I, Barrett JC, Schlegel R . 2001 J. Virol. 75: 4467–4472
Wang Z, Kyo S, Takakura M, Tanaka M, Yatabe N, Maida Y, Fujiwara M, Hayakawa J, Ohmichi M, Koike K, Inoue M . 2000 Cancer Res. 60: 5376–5381
Wang J, Xie LY, Allan S, Beach D, Hannon GJ . 1998 Genes Dev. 12: 1769–1774
Watson JD . 1972 Nat. New. Biol. 239: 197–201
Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, Bodnar AG, Lichtsteiner S, Kim NW, Trager JB, Taylor RD, Carlos R, Andrews WH, Wright WE, Shay JW, Harley CB, Morin GB . 1997 Nat. Genet. 17: 498–502
Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, Dalla-Favera R . 1999 Nat. Genet. 21: 220–224
Xu D, Popov N, Hou M, Wang Q, Bjorkholm M, Gruber A, Menkel AR, Henriksson M . 2001 Proc. Natl. Acad. Sci. USA 98: 3826–3831
Xu D, Wang Q, Gruber A, Bjorkholm M, Chen Z, Zaid A, Selivanova G, Peterson C, Wiman KG, Pisa P . 2000 Oncogene 19: 5123–5133
Yasumoto S, Kunimura C, Kikuchi K, Tahara H, Ohji H, Yamamoto H, Ide T, Utakoji T . 1996 Oncogene 13: 433–439
Yi X, White DM, Aisner D, Baur JA, Wright WE, Shay JW . 2000 Neoplasia 2: 433–440
Zhang W, Kapusta LR, Slingerland JM, Klotz LH . 1998 Cancer Res. 58: 619–621
Zhu X, Kumar R, Mandal M, Sharma N, Sharma HW, Dhingra U, Sokoloski JA, Hsiao R, Narayanan R . 1996 Proc. Natl. Acad. Sci. USA 93: 6091–6095
Acknowledgements
We thank Professor Jerry Shay for configuring the manuscript and providing helpful advice and discussion.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kyo, S., Inoue, M. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: How can we apply them for cancer therapy?. Oncogene 21, 688–697 (2002). https://doi.org/10.1038/sj.onc.1205163
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205163
Keywords
This article is cited by
-
THOR is a targetable epigenetic biomarker with clinical implications in breast cancer
Clinical Epigenetics (2022)
-
Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer
Journal of Biomedical Science (2018)
-
New insights into vitamin D anticancer properties: focus on miRNA modulation
Molecular Genetics and Genomics (2017)
-
Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer: a case–control study in northeast Chinese male population
Medical Oncology (2014)
-
Compounds from Allium species with cytotoxic and antimicrobial activity
Phytochemistry Reviews (2014)